C.J.A. Punt

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot et al. · New England Journal of Medicine · 2012 · 5.3K citations · Full text

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +9

Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206) and chemotherapy (temozolomide [TMZ] or dacarbazine [DTIC]) in patients with advanced melanoma

A. Ribas, Axel Hauschild, Richard Kefford et al. · Journal of Clinical Oncology · 2008 · 156 citations

Tremelimumab 15, Tremelimumab Arm, Immunology +18

Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)

C.J.A. Punt, J. Tol, C. J. Rodenburg et al. · Journal of Clinical Oncology · 2008 · 130 citations

Cancer Management, Immunology, Pathology +20

Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer

Amanda C. R. K. Bos, Felice N. van Erning, Yvette R.B.M. van Gestel et al. · European Journal of Cancer · 2015 · 124 citations

Oncology, Gastrointestinal Oncology, Cancer Management +6